A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults.
Saved in:
| Title: | A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults. |
|---|---|
| Authors: | Rostad CA; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Atmar RL; Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA., Walter EB; Department of Pediatrics and Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA., Frey S; Center for Vaccine Development, Saint Louis University, St. Louis, Missouri, USA., Meier JL; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Sherman AC; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Lai L; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Tsong R; Emmes, Inc., Rockville, Maryland, USA., Kao CM; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Raabe V; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.; New York University Langone Vaccine Center, NYU Grossman School of Medicine, New York, New York, USA., El Sahly HM; Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA., Keitel WA; Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA., Whitaker JA; Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, Texas, USA., Smith MJ; Department of Pediatrics and Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA., Schmader KE; Department of Medicine-Geriatrics, Duke University and GRECC, Durham VA Health Care System, Durham, North Carolina, USA., Swamy GK; Department of Obstetrics and Gynecology and Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA., Abate G; Center for Vaccine Development, Saint Louis University, St. Louis, Missouri, USA., Winokur P; Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Buchanan W; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Cross K; Emmes, Inc., Rockville, Maryland, USA., Wegel A; Emmes, Inc., Rockville, Maryland, USA., Xu Y; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Yildirim I; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Kamidani S; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Rouphael N; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Roberts PC; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Mulligan MJ; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.; New York University Langone Vaccine Center, NYU Grossman School of Medicine, New York, New York, USA., Anderson EJ; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.; Center for Childhood Infections and Vaccines, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Hope Clinic, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jun 14; Vol. 78 (6), pp. 1757-1768. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6591 |
|---|---|
| DOI: | 10.1093/cid/ciae173 |
